<DOC>
	<DOCNO>NCT01011075</DOCNO>
	<brief_summary>This study evaluate clinical efficacy combine Gleevec ( imatinib mesylate ) , PDGFR antagonist , front-line , single-agent paclitaxel cohort elderly patient advance , non-small cell lung cancer .</brief_summary>
	<brief_title>Study Gleevec Weekly Paclitaxel Patients Aged 70 Older With Advanced Non-small Cell Lung Cancer</brief_title>
	<detailed_description>Paclitaxel 90 mg/m2 IV day 3 , 10 , 17 Imatinib 600 mg/day , oral administration 4-day pulse bracket paclitaxel infusion ( day 1-4 ; 8-11 ; 15-18 ) Cycle length : 28 day Number cycle : 6</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>Age ≥ 70 year Histologic cytologic diagnosis nonsmall cell lung cancer At least one site measurable disease , define modify RECIST criterion ( See section 7.6 ) Stage IIIB pleural effusion Stage IV disease . Includes patient receive surgery alone early stage disease , relapse advance disease . Staging accord American Joint Committee Cancer classification scheme , 6th edition.48 Adequate hepatic , renal marrow function Liver function test : total bilirubin &lt; 1.25 x upper limit normal ( ULN ) , AST ALT &lt; 2.5 x ULN , Creatinine &lt; 1.5 x ULN Baseline absolute neutrophil count &gt; 1500/μL Baseline platelet count &gt; 100,000/μL ECOG Performance Status 0 , 1 2 time inform consent . ( See Appendix 1 ) Written , voluntary consent Patients reproductive potential must use acceptable contraceptive method . Such method include : 1 ) Male hormonal contraception ; 2 ) Partner without reproductive potential , include postmenopausal status history tubal ligation ; 3 ) Partner intrauterine device ( IUD ) contraceptive vaginal ring ; 4 ) Partner take oral contraceptive pill , wear contraceptive patch , contraceptive implant ; 5 ) Routine use barrier method , condom diaphragm , sexual intercourse . Uncontrolled brain metastasis . Patients know brain metastasis must complete treatment surgery , radiation . In addition , must corticosteroids . Symptomatic neuropathy ( Grade 2 high ) Prior chemotherapy advance nonsmall cell lung cancer . ( Prior adjuvant , neoadjuvant , chemoradiotherapy NSCLC permit , provide least 6 month elapse prior document metastatic recurrence . ) Patient &lt; 5 year free another primary malignancy , except : ) malignancy basal cell carcinoma cervical carcinoma situ b ) primary malignancy consider clinically significant require active intervention Prior radiation therapy &gt; 25 % bone marrow Grade III/IV congestive heart failure , define NYHA criterion , myocardial infarction within 6 month . Any serious uncontrolled concomitant disorder , opinion investigator , would compromise patient 's ability complete study . Patient know chronic liver disease , e.g . diagnosis chronic active hepatitis cirrhosis . Major surgery two week prior study treatment Patient significant history noncompliance medical regimen inability grant reliable informed consent Any condition require continuous administration systemic corticosteroid . The patient therapeutic anticoagulation warfarin .</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Lung cancer ,</keyword>
	<keyword>Non-small cell lung cancer</keyword>
	<keyword>NSCLC</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Gleevec</keyword>
	<keyword>elderly</keyword>
</DOC>